Citadel Advisors
TWST icon

Citadel Advisors’s Twist Bioscience TWST Stock Holding History

Citadel Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.57M Buy
54,100
+4,600
+9% +$206K ﹤0.01% 5562
2025
Q4 		$1.57M Buy
49,500
+25,900
+110% +$808K ﹤0.01% 6411
2025
Q3 		$664K Buy
23,600
+2,900
+14% +$87.8K ﹤0.01% 8456
2025
Q2 		$762K Sell
20,700
-6,100
-23% -$211K ﹤0.01% 7672
2025
Q1 		$1.05M Sell
26,800
-3,000
-10% -$135K ﹤0.01% 6844
2024
Q4 		$1.38M Buy
29,800
+6,900
+30% +$312K ﹤0.01% 6384
2024
Q3 		$1.03M Sell
22,900
-18,700
-45% -$890K ﹤0.01% 6802
2024
Q2 		$2.05M Sell
41,600
-6,700
-14% -$273K ﹤0.01% 5249
2024
Q1 		$1.66M Buy
48,300
+26,100
+118% +$942K ﹤0.01% 5894
2023
Q4 		$818K Buy
22,200
+14,100
+174% +$326K ﹤0.01% 7086
2023
Q3 		$164K Sell
8,100
-24,800
-75% -$545K ﹤0.01% 10212
2023
Q2 		$673K Buy
32,900
+5,300
+19% +$79.4K ﹤0.01% 7271
2023
Q1 		$416K Sell
27,600
-29,200
-51% -$645K ﹤0.01% 8679
2022
Q4 		$1.35M Buy
56,800
+37,100
+188% +$1.08M ﹤0.01% 6237
2022
Q3 		$694K Sell
19,700
-10,200
-34% -$433K ﹤0.01% 7762
2022
Q2 		$1.04M Sell
29,900
-15,300
-34% -$542K ﹤0.01% 6917
2022
Q1 		$2.23M Buy
45,200
+27,000
+148% +$1.5M ﹤0.01% 5845
2021
Q4 		$1.41M Sell
18,200
-11,400
-39% -$1.17M ﹤0.01% 7037
2021
Q3 		$3.17M Sell
29,600
-8,500
-22% -$973K ﹤0.01% 5241
2021
Q2 		$5.08M Sell
38,100
-41,500
-52% -$4.82M ﹤0.01% 4397
2021
Q1 		$9.86M Buy
79,600
+50,700
+175% +$7.7M ﹤0.01% 2979
2020
Q4 		$4.08M Buy
28,900
+10,400
+56% +$1.15M ﹤0.01% 4019
2020
Q3 		$1.41M Buy
18,500
+8,400
+83% +$523K ﹤0.01% 5395
2020
Q2 		$458K Buy
+10,100
New +$362K ﹤0.01% 7249

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors's TWST Position: Q1 2026 in Review

Citadel Advisors increased its Twist Bioscience (TWST) stake by 3,708% in Q1 2026, buying an estimated $53.3M and bringing the position to 1,220,400 shares worth $58M. The position accounts for 0.01% of the portfolio, ranked #1226.

Citadel Advisors first reported a position in TWST in Q3 2019 and has held it in 26 quarters since. The position peaked at $70.4M in Q2 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Citadel Advisors held 1,220,400 shares of Twist Bioscience worth $58M as of Q1 2026.
  • Citadel Advisors bought 1,188,351 Twist Bioscience shares in Q1 2026, an estimated $53.3M.
  • Twist Bioscience made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1226 holding.
  • Citadel Advisors first reported a position in Twist Bioscience in Q3 2019 and has held it in 26 quarters since.
  • Citadel Advisors's Twist Bioscience position peaked at $70.4M in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.